Shukra Pharmaceuticals Limited (BOM:524632)
India flag India · Delayed Price · Currency is INR
40.78
-0.65 (-1.57%)
At close: Mar 9, 2026

Shukra Pharmaceuticals Company Description

Shukra Pharmaceuticals Limited manufactures and markets pharmaceutical products in India and internationally.

Its product portfolio includes macrolides, quinolones, anti-bacterial, anti-fungal, anti-malarial, anti-viral, anti-protozoal, anti-anthelmintic, sedative and tranquillizer, anti-depressant, anti-manic, anti-emetic, anti-ulcer, beta blockers, diuretics, analgesic, muscle relaxants, anti-tuberculosis, vitamin products, anti-allergics, corticosteroids, hyper and hypoglycemic, and other products, as well as antibiotics, such as penicillin and cephalosporin.

The company was formerly known as Relish Pharmaceuticals Limited and changed its name to Shukra Pharmaceuticals Limited in August 2016.

Shukra Pharmaceuticals Limited was incorporated in 1993 and is based in Ahmedabad, India.

Shukra Pharmaceuticals Limited
Country India
Founded 1993
Industry Pharmaceutical Preparations
Employees 115
CEO Dakshesh Shah

Contact Details

Address:
Veer House
Ahmedabad, 380054
India
Phone 91 79 2749 8515
Website shukrapharmaceuticals.com

Stock Details

Ticker Symbol 524632
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2834

Key Executives

Name Position
Dakshesh Shah Chief Executive Officer
Anar Patel Chief Financial Officer